WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Diviya Padman
Associate
Corporate
London
dpadman@wsgr.com

D44-20-39634055

Download vCard
Open PDF

Diviya Padman is a U.S.-qualified corporate associate in the London office of Wilson Sonsini Goodrich & Rosati, where she specializes in advising innovative businesses and those who invest in them on general U.S. corporate and transactional matters. She focuses on supporting UK and other European-based companies through their U.S. life cycle—including U.S. expansion, venture and growth capital financings, partnerships, acquisitions, and sale or IPO—and assists management teams, venture capital funds, business angels, angel groups, and other individuals to buy, sell, merge, or fund businesses locally, nationally, and internationally.

In addition to her legal qualifications, Diviya has an academic background in medical sciences, which helps her to work closely with and understand complex language associated with businesses in the technology, pharmaceutical, and life science sectors.

Diviya joined the firm in 2018, having previously worked for several years with UK-based technology companies from corporate formation to exit at a boutique corporate and commercial law firm in Cambridge, UK. Diviya also is qualified as a solicitor in England and Wales.

Experience

Diviya Padman is a U.S.-qualified corporate associate in the London office of Wilson Sonsini Goodrich & Rosati, where she specializes in advising innovative businesses and those who invest in them on general U.S. corporate and transactional matters. She focuses on supporting UK and other European-based companies through their U.S. life cycle—including U.S. expansion, venture and growth capital financings, partnerships, acquisitions, and sale or IPO—and assists management teams, venture capital funds, business angels, angel groups, and other individuals to buy, sell, merge, or fund businesses locally, nationally, and internationally.

In addition to her legal qualifications, Diviya has an academic background in medical sciences, which helps her to work closely with and understand complex language associated with businesses in the technology, pharmaceutical, and life science sectors.

Diviya joined the firm in 2018, having previously worked for several years with UK-based technology companies from corporate formation to exit at a boutique corporate and commercial law firm in Cambridge, UK. Diviya also is qualified as a solicitor in England and Wales.

Education
  • Postgraduate Diploma in Legal Practice (LPC), BPP University, Cambridge, United Kingdom, 2014
  • LL.B. Hons., University of Leeds, United Kingdom, 2013
  • B.S., Medical Sciences, University of Leeds, United Kingdom, 2010
Admissions
  • State Bar of California
  • Solicitor, England and Wales
Credentials
Education
  • Postgraduate Diploma in Legal Practice (LPC), BPP University, Cambridge, United Kingdom, 2014
  • LL.B. Hons., University of Leeds, United Kingdom, 2013
  • B.S., Medical Sciences, University of Leeds, United Kingdom, 2010
Admissions
  • State Bar of California
  • Solicitor, England and Wales
Focus Areas
  • Animal Health
  • Corporate
  • Corporate Governance
  • Emerging Companies and Venture Capital
  • Mergers & Acquisitions
  • Shareholder Engagement and Activism
  • U.S. Expansion
Recent Insights
Client Highlights
Wilson Sonsini Advises Protex AI on $36 Million Series B
On January 29, 2025, Protex AI, the global leader in AI-driven workplace safety technology, announced it has secured an oversubscribed $36 million Series B funding round. The round was led by Hedosophia with participation from Salesforce Ventures and existing investors Elkstone, firstminute capital, Notion Capital, and Playfair. Wilson Sonsini Goodrich & Rosati advised Protex AI on the transaction.

This latest investment comes as Protex AI accelerates its expansion in the U.S. to revolutionize worker safety on a global scale through computer vision and AI. This funding round will allow the company to expand its U.S. presence and focus on bringing top-tier talent into the fold to continue driving innovation and enabling Protex AI’s growth.
Learn More
Client Highlights
Wilson Sonsini Advises 9fin on $50 Million Funding to Invest in AI and Pursue U.S. Expansion
On December 2, 2024, 9fin, the AI-powered analytics platform for debt capital markets, announced it has raised $50 million in a Series B round led by Highland Europe, with participation from existing investors Spark Capital, Redalpine, Seedcamp, 500 Startups, and Ilavska Vuillermoz Capital. The new funding will enable 9fin to invest further in its market-leading AI technology, grow its analytics team, and accelerate its expansion in the U.S.
Learn More
View All
Recent Events
Affiliated Programs
Angel Investor v. Venture Capitalist: Finding the Right Fit When Fundraising for Your US/UK Life Sciences or Biotech Company
Raising capital as a start-up can be daunting—from creating pitches to understanding which investors might best suit your company’s mission. The process of raising commercial funding for early-stage life sciences and biotech businesses is very different from obtaining research funding, and it can be challenging for founders to decide which investors to target, where to source them and how to approach them.
Learn More
Affiliated Programs
ALL IN – EmpowerHer’s Unlocking Investment for Female Founders
According to the Rose Review (June 2023), all-female teams received only 1% of VC funding in the UK. Successful fundraising is the lifeblood of startups, and we aim to change this statistic. Our event is focused on providing the tools and insights needed to break down barriers and create equal access to capital.  Gain insights from a powerhouse panel of successful female founders and investment experts. They'll discuss strategies and opportunities to help women entrepreneurs secure the funding they need.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.